Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
8 participants
OBSERVATIONAL
2013-05-01
2015-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators hypothesized:
* DMD patients have a high prevalence of constipation than in the general population.
* Prevalence of constipation will increase with age and with worsening functional status.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Use of an Ambulatory Capsule to Characterize Gastrointestinal Pressure Patterns in Children
NCT01026922
Mechanisms of Action for the Enterra Medical Gastric Electrical Stimulator
NCT06582576
Prospective Multisite Study of Quality of Life in Pediatric Intestinal Failure
NCT04629014
Domperidone in Refractory Gastroparesis
NCT00760461
The Motility Mother-Child Cohort
NCT05491161
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Constipation Assessment:
* The patient will be asked to complete a questionnaire about any symptoms of constipation.
* A physician from the study team will perform an abdominal physical exam
* The patient will have routine x-rays that monitor for spine compression fractures. These films will also be used to assess stool content.
Clinical Information The following information will also be collected during the clinic visit ;
* Age at diagnosis and genetic mutation
* Age at loss of ambulation if applicable
* Medications
* Functional status
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Motility
This arm will ingest the SmartPill.
SmartPill ingestion
The participant would ingest the SmartPill and wear the data receiver for up to 5 days.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SmartPill ingestion
The participant would ingest the SmartPill and wear the data receiver for up to 5 days.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age greater than or equal to 18 years old
Exclusion Criteria
18 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Children's Hospital Medical Center, Cincinnati
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ajay Kaul, MD
Role: STUDY_CHAIR
Children's Hospital Medical Center, Cincinnati
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2013-1312
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.